Logo Image
|Articles|May 1, 2001

Pharmaceutical Executive

  • Pharmaceutical Executive-05-01-2001
  • Volume 0
  • Issue 0

Task Force: Enter the Fixers

Author(s)Kevin Gopal

A new task force will examine European pharma}s competitiveness, innovation, and commitment to public health. The "G10" is not, as it may sound, an enlarged grouping of the world}s leading industrialized countries. It}s actually far more important than that.

Articles in this issue

over 25 years ago

Policy: Task Masters

over 25 years ago

Pharmacia's Carrie Cox: HBA Woman of the Year

over 25 years ago

Friends of Complexity

over 25 years ago

Under Federal Fire

over 25 years ago

The Next Y2K

over 25 years ago

Political Science

Related to this article

View more
Pharmaceutical Executive Daily
Pharmaceutical Executive Daily: FDA Approves Tecentriq
The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new IPOs, and a Pharmaceutical Executive feature examines what it takes to turn precision medicine’s biological gains into deliverable therapies.
Read more
Naoki Okamura: Post-Patent Plan and Purpose
Naoki Okamura: Post-Patent Plan and Purpose
Astellas CEO Naoki Okamura is putting a “patient axis” operating model, a broader portfolio of strategic brands and a new generation of science to work in the company’s bid to return to record growth.
Read more